Dr Chaitenya Verma, PhD

Immunology — Sharda University, India

LeadR Profile

Dr Chaitenya Verma, PhD Sharda University India
121 ScienceLeadR Reputation 121
Network Map

Immunology

Subspecialties: Biochemistry - Infectiology - Oncology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2007 - 2026

Source: PubMed

The Ohio State University

could not re-read experiences after save", error); return null; } if (persistedEntries === null) { return null; } if (persistedEntries.length === 0 && sent.some((entry) => entry.isvisible !== false)) { console.warn(" re-read after save came back empty, keeping the edited entries"); return null; } this.state.current.experience = persistedEntries; const expected = this.yearsSignature(sent); const received = this.yearsSignature(persistedEntries.map((entry) => ({ isvisible: entry.isvisible, topresent: entry.topresent, year_start: entry.startperiod, year_stop: entry.endperiod }))); if (expected !== received) { console.error(" saved experiences were not persisted as sent", { sent: expected, received: received }); return false; } return true; }, async fetchExperiences() { const response = await $.ajax({ url: ajaxLoadUserData, type: "POST", data: { security: ajaxDataLoadUserData.security, data_to_load: "OrganizationHisto", } }); const parsedData = JSON.parse(response); if (parsedData.loaded === false || !parsedData.user_data || !Array.isArray(parsedData.user_data)) { return null; } return parsedData.user_data.map((value, index) => ({ company: value["name"], url: "", position: (value.hasOwnProperty("position") ? ( value["position"] ) : ( "" ) ), startperiod: value["year_start"], endperiod: value["year_stop"], topresent: (value.hasOwnProperty("topresent") ? ( value["topresent"] ) : ( false ) ), orgid: value["orgid"], isvisible: (value.hasOwnProperty("isvisible") ? ( value["isvisible"] ) : ( true ) ), description: "", tags: [], isOpen: false, ismain: (value.hasOwnProperty("ismain") ? ( value["ismain"] ) : ( (index === 0) ? true : false ) ) })); }, async loadDataOnMount() { this.loading = true; try { const experiences = await this.fetchExperiences(); this.loadFailed = experiences === null; if (experiences !== null) { this.state.current.experience = experiences; } } catch (error) { console.warn(" could not load experiences", error); this.loadFailed = true; } this.loading = false; } }, computed: { experience: { get() { return this.state.current.experience }, }, }, async mounted() { await this.loadDataOnMount() }, } }; })

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 44

Citations

Citations: 325 1st author: 7 Last author: 4 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Editorial: Host-pathogen interactions: cellular damage, death, and adaptation in microbial infections.
host-pathogen interactions, cell biology, cell death, infections
Front Cell Infect Microbiol20260
Microneedle-based injection of Fungizone/Amphotericin B: an effective treatment for American cutaneous leishmaniasis in mice.
injections, growth, blood, serum, pharmaceutical preparations, leishmaniasis, cutaneous, drug delivery systems, amphotericin b, therapeutics, leishmaniasis, microneedle drug delivery
Drug Deliv20260
Prognostic Significance and Immune Correlation of CCL3 Expression in Colon Adenocarcinoma: Insights From Multidatabase Analysis.
genes, neoplasms, adenocarcinoma, colon, drug therapy, chemotherapy
Biochem Res Int20260
DNA Methylation in Lung Cancer: Predictive Biomarkers for Effective Immunotherapy.
genes, lung, neoplasms, biomarkers, immunotherapy, dna methylation, lung neoplasms, therapeutics, dna, tumor microenvironment, microsatellite instability
Int J Gen Med20250
Amentoflavone Impedes NF-κB Activation and Mediates Apoptosis Induction in Lung Cancer Cells: An in vitro and in silico exploration.
cells, a549 cells, genes, lung, mitochondrial membranes, pharmaceutical preparations, cell survival, membrane potentials, doxorubicin, neoplasms, carcinoma, non-small-cell lung, caspases, membrane potential, mitochondrial, lung neoplasms, therapeutics, apoptosis, membranes
J Inflamm Res20250

LeadR Networks

Main global connection map